CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in CalciMedica, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +1 vs. Q3 2025
- Shares held
- 3.68M
- +161.0K (+4.6%) vs. Q3 2025
- Total value
- $24.2M
- +$13.5M (+124.7%) vs. Q3 2025
- New holders
- 7
- 5 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 10 | $66 | 0.00% | +10 | New |
| BNP Paribas Arbitrage, SA | 19 | $125 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 90 | $593 | 0.00% | −32−26.2% | Reduced |
| Advisor Group Holdings, Inc. | 107 | $705 | 0.00% | −931−89.7% | Reduced |
| Brown Brothers Harriman & Co | 308 | $2.03K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,100 | $7.25K | 0.00% | +1,083+6,370.6% | Added |
| Bank of America Corp | 9,027 | $59.5K | 0.00% | −5−0.1% | Reduced |
| Rockefeller Capital Management L.P. | 10,000 | $65.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 12,530 | $82.6K | 0.00% | +12,530 | New |
| First Manhattan Co | 13,226 | $87.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 14,855 | $97.9K | 0.00% | −19,533−56.8% | Reduced |
| TritonPoint Partners, LLC | 15,119 | $99.6K | 0.05% | +15,119 | New |
| J. Goldman & Co LP | 18,900 | $124.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,203 | $126.5K | 0.00% | +19,203 | New |
| Sound View Wealth Advisors Group, LLC | 20,100 | $132.5K | 0.01% | 00.0% | Unchanged |
| Cetera Investment Advisers | 22,290 | $146.9K | 0.00% | −3,075−12.1% | Reduced |
| Timothy G. Youngquist 2020 Irrevocable Trust | 23,753 | $156.5K | 0.13% | +23,753 | New |
| Atria Investments LLC | 28,781 | $189.7K | 0.00% | −9,305−24.4% | Reduced |
| 180 Wealth Advisors, LLC | 31,850 | $209.9K | 0.02% | −10,850−25.4% | Reduced |
| Summit Financial, LLC | 35,484 | $233.8K | 0.00% | +10,392+41.4% | Added |
| PVG Asset Management Corp | 45,830 | $302.0K | 0.64% | +45,830 | New |
| Stonehage Fleming Financial Services Holdings Ltd | 53,703 | $353.9K | 0.01% | 00.0% | Unchanged |
| Meritage Portfolio Management | 61,539 | $405.5K | 0.03% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 63,186 | $416.4K | 0.00% | −13,519−17.6% | Reduced |
| Boothbay Fund Management, LLC | 76,855 | $506.5K | 0.01% | +76,855 | New |
| Renaissance Technologies LLC | 88,300 | $581.9K | 0.00% | +18,300+26.1% | Added |
| Geode Capital Management, LLC | 99,787 | $657.6K | 0.00% | +935+0.9% | Added |
| Vanguard Group Inc | 407,801 | $2.69M | 0.00% | +31,177+8.3% | Added |
| Aisling Capital Management LP | 521,114 | $3.43M | 0.72% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 683,904 | $4.51M | 0.19% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,300,000 | $8.57M | 0.11% | 00.0% | Unchanged |
| Tritonpoint Wealth, LLC | 0 | $0 | 0.00% | −15,119−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,345−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,927−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −856−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Sheets Smith Investment Management | – | – | – | – | Not filed |